Tertiary Education Trust Fund (TETFund), has enlisted 12 Nigerian universities as pioneer centres of excellence to spearhead research and development programmes that would contribute to national growth. The universities includes University of Abuja(UNIABUJA), University of Benin(UNIBEN), University of Ibadan (UI), University of Maiduguri (UNIMAD), Bayero University Kano (BUK), Nnamdi Azikiwe University (UNIZIK), Akwa, University of Uyo (UNIUYO), and Micheal Okpara University of Agriculture, Umudike. Others are University of Jos (UNIJOS), University of Lagos (UNILAG), Abubakar Tafawa Balewa University (ATBU) and Uthman Danfodio University, Sokoto. The Executive Secretary of TETFund, Suleiman Bogoro presenting allocation letters and guidelines to Vice Chancellors of…

It sounds like science fiction: giant solar power stations floating in space that beam down enormous amounts of energy to Earth. And for a long time, the concept – first developed by the Russian scientist, Konstantin Tsiolkovsky, in the 1920s – was mainly an inspiration for writers. A century later, however, scientists are making huge strides in turning the concept into reality. The European Space Agency has realised the potential of these efforts and is now looking to fund such projects, predicting that the first industrial resource we will get from space is “beamed power”. Climate change is the greatest…

A group of scientists have discovered a “more elegant chemotherapy” that can accurately target cancerous cells in a first in the battle against the disease. The research successfully killed cancerous cells while leaving healthy ones around it using a technique which relies on DNA editing tools. The technology has already been used in mice and could be used on humans as soon as within the next two years, the scientists said. Professor Dan Peer, a cancer expert from Israel’s Tel Aviv University, explained that there are “no side effects” and they believe that a “cancer cell treated in this way…

The vaccine developed by the University of Oxford stops 70% of people developing Covid symptoms, a large scale trial shows. It is both a triumph and a disappointment after vaccines by Pfizer and Moderna showed 95% protection. However, the Oxford jab is far cheaper, and is easier to store and get to every corner of the world than the other two. So it will still play a significant role in tackling the pandemic, if it is approved by regulators. The Oxford researchers have performed the normally decade-long process of developing a vaccine in around 10 months. The UK government has…